HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PETA Names Cosmetic Firms Suspected Of Flouting EU Animal-Test Ban

This article was originally published in The Rose Sheet

Executive Summary

The Estee Lauder Companies, Revlon, Clarins, Dior and Benefit Cosmetics are among firms that PETA says may be illegally marketing cosmetics in the UK that also are registered in China, where animal testing is routinely required. The animal-rights group seeks enforcement action from British officials to uphold the EU's ban on cosmetic animal testing.

You may also be interested in...



Highest European Court To Rule On Animal-Testing Ban's Scope In 2016

The EU's ban on animal-tested cosmetics and ingredients could be narrowly limited to tests performed to meet the European Cosmetics Regulation's data requirements – exempting testing undertaken to comply with third-country regulations or other EU laws – if the European Court of Justice sides with industry next year. Stakeholders expect the court's advocate general to render an opinion on the matter in March 2016.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel